Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use

Saccharomyces cerevisiae has recently been used as an ingredient in probiotic supplements. Invasive Saccharomyces infection have been documented, and multiple predisposing risk factors have been identified including critical illness, ICU admission, antibiotics use, central venous catheters, probioti...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadhel, Mustafa, Patel, Swapnil, Liu, Edward, Levitt, Michael, Asif, Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251791/
https://www.ncbi.nlm.nih.gov/pubmed/30505677
http://dx.doi.org/10.1016/j.mmcr.2018.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251791/
https://www.ncbi.nlm.nih.gov/pubmed/30505677
http://dx.doi.org/10.1016/j.mmcr.2018.11.003

Ejemplares similares